Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent. Continue reading →

Marketing Trumps Safety: the case of Antipsychotics

"The story’s pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale. Continue reading →

Florida Antipsychotic Pre-Approval Requirement Protects PreschoolChildren

The State of Florida has established a pre-approval requirement to protect preschool children on Medicaid from being exposed to the hazardous effects of antipsychotic drugs. That step has prompted "a seismic change" in doctors’ inappropriate prescribing of antipsychotics for preschool children: the . . . Continue reading →

Biederman J & J Risperdal Documents

A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing division-provide a bird’s eye view of collusion between the drug giant and Harvard’s leading child psychiatrist, Dr. Joseph Biederman, and one of Harvard’s premier teaching hospitals, Massachusetts General Hospital.
Continue reading →

Letter of Complaint to FDA Commissioner, 2007

vera_signature.png

Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without  an advisory panel or open public discussion.  Continue reading →

Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by Zyprexa

The deceptive marketing of antipsychotic drugs has prompted new advocacy group to launch "The Just Say "Know" to Prescription Drugs Campaign."  Its goal is to get one million people to stop and reevaluate the medications they are taking. Continue reading →

Pfizer CEO Urges Staff to Mobilize & Lobby Congress Against Drug Price Controls

To gain insight into how a pharmaceutical giant is revving up itsr troops to lobby Congress against the legislation. See Pfizer CEO’s directive to the entire staff exhorting them to mobilize and lobby Congress to vote against drug price controls. http://www.pfizerfactfiction.com/mma/flash.html   
 

Continue reading →